Skip to Content
Merck
CN

V800101

Calcium carbonate

AR, ≥98.5%

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
CaCO3
CAS Number:
Molecular Weight:
100.09
EC Number:
207-439-9
UNSPSC Code:
12352300
PubChem Substance ID:
Beilstein/REAXYS Number:
8008338
MDL number:
Assay:
≥98.5%
Grade:
AR
Form:
powder
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


grade

AR

product line

Vetec

assay

≥98.5%

form

powder

pH

8

density

2.93 g/mL at 25 °C (lit.)

anion traces

chloride (Cl-): ≤0.005%, sulfate (SO42-): ≤0.005%

cation traces

Ba: ≤0.01%, Cu: ≤0.0005%, Fe: ≤0.001%, K: ≤0.005%, Mg: ≤0.02%, Na: ≤0.10%, heavy metals (as Pb): ≤0.0005%

SMILES string

[Ca++].[O-]C([O-])=O

InChI

1S/CH2O3.Ca/c2-1(3)4;/h(H2,2,3,4);/q;+2/p-2

InChI key

VTYYLEPIZMXCLO-UHFFFAOYSA-L

Legal Information

Vetec is a trademark of Merck KGaA, Darmstadt, Germany


Still not finding the right product?

Explore all of our products under Calcium carbonate


Storage Class

13 - Non Combustible Solids

wgk

nwg

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



M Azizur Rahman et al.
PloS one, 8(3), e58781-e58781 (2013-03-26)
An organic matrix consisting of a protein-polysaccharide complex is generally accepted as an important medium for the calcification process. While the role this "calcified organic matrix" plays in the calcification process has long been appreciated, the complex mixture of proteins
Jane A Cauley et al.
Journal of women's health (2002), 22(11), 915-929 (2013-10-18)
Clinical outcomes of the Women's Health Initiative (WHI) calcium plus vitamin D supplementation trial have been reported during 7.0 years of active intervention. We now report outcomes 4.9 years after the intervention stopped and cumulative findings. Postmenopausal women (N=36,282) were
Sophie A Jamal et al.
Lancet (London, England), 382(9900), 1268-1277 (2013-07-23)
Phosphate binders (calcium-based and calcium-free) are recommended to lower serum phosphate and prevent hyperphosphataemia in patients with chronic kidney disease, but their effects on mortality and cardiovascular outcomes are unknown. We aimed to update our meta-analysis on the effect of



Global Trade Item Number

SKUGTIN
V800101-500G04061832599229
V800101-6X500G04061832599236